|
US8147824B2
(en)
|
1999-08-05 |
2012-04-03 |
Athersys, Inc. |
Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
|
|
US8142819B2
(en)
*
|
2002-10-21 |
2012-03-27 |
Metaproteomics, Llc |
Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
|
|
US7901714B2
(en)
*
|
2001-06-20 |
2011-03-08 |
Metaproteomics, Llp |
Treatment modalities for autoimmune diseases
|
|
US7815944B2
(en)
*
|
2001-06-20 |
2010-10-19 |
Metaproteomics, Llc |
Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity
|
|
US8168234B2
(en)
*
|
2001-06-20 |
2012-05-01 |
Metaproteomics, Llc |
Compositions that treat or inhibit pathological conditions associated with inflammatory response
|
|
US7901713B2
(en)
*
|
2001-06-20 |
2011-03-08 |
Metaproteomics, Llc |
Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
|
|
US8206753B2
(en)
*
|
2001-06-20 |
2012-06-26 |
Metaproteomics, Llc |
Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
|
|
US20040115290A1
(en)
*
|
2001-06-20 |
2004-06-17 |
Tripp Matthew L. |
Modulation of inflammation by hops fractions and derivatives
|
|
US6638981B2
(en)
*
|
2001-08-17 |
2003-10-28 |
Epicept Corporation |
Topical compositions and methods for treating pain
|
|
US8158160B2
(en)
|
2001-11-13 |
2012-04-17 |
Eric Hauser Kuhrts |
Anti-inflammatory cyclooxygenase inhibitors
|
|
US20040071666A1
(en)
*
|
2002-05-24 |
2004-04-15 |
The Regents Of The University Of Michigan |
Compositions and methods related to graft-versus-host disease
|
|
CN1324026C
(zh)
*
|
2002-09-23 |
2007-07-04 |
东北制药总厂 |
硫酸黄连素的制备方法
|
|
KR20050071605A
(ko)
*
|
2002-10-21 |
2005-07-07 |
메타프로테오믹스, 엘엘씨 |
염증반응과 관련된 병리학적 상태를 치료하거나 저해하는조성물
|
|
KR20060105429A
(ko)
|
2003-05-22 |
2006-10-11 |
메타프로테오믹스, 엘엘씨 |
염증을 약화시키기 위한 항염증성 약제학적 조성물 및 위의독성의 치료법 또는 예방법
|
|
US20050192356A1
(en)
*
|
2004-02-27 |
2005-09-01 |
Babish John G. |
Synergistic anti-inflammatory pharmaceutical compositions and methods of use
|
|
US7914831B2
(en)
*
|
2004-02-27 |
2011-03-29 |
Metaproteomics, Llc |
Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
|
|
EP2263663A1
(en)
*
|
2004-11-13 |
2010-12-22 |
Metaproteomics, LLC |
Compositions comprising curcuminoids and either alpha or beta acids for use in the treatment of diabetes
|
|
CA2618613A1
(en)
*
|
2005-08-09 |
2007-02-22 |
Metaproteomics, Llc |
Protein kinase modulation by hops and acacia products
|
|
US10117900B2
(en)
|
2005-11-09 |
2018-11-06 |
Athersys, Inc. |
MAPC treatment of brain injuries and diseases
|
|
US11000546B2
(en)
|
2005-11-09 |
2021-05-11 |
Athersys, Inc. |
Immunomodulatory properties of MAPCs and uses thereof
|
|
JP2009518439A
(ja)
*
|
2005-12-09 |
2009-05-07 |
メタプロテオミクス，エルエルシー |
ホップ及びアカシア産物によるプロテインキナーゼ調節
|
|
CA3124132A1
(en)
|
2006-01-23 |
2007-08-02 |
Abt Holding Company |
Mapc therapeutics without adjunctive immunosuppressive treatment
|
|
US20080124404A1
(en)
*
|
2006-06-19 |
2008-05-29 |
Jingwen Liu |
Hypolipidemic and/or hypocholesteremic compounds obtainable from the goldenseal plant
|
|
US20080051466A1
(en)
*
|
2006-06-20 |
2008-02-28 |
Metaproteomics, Llc |
Isoalpha acid based protein kinase modulation cancer treatment
|
|
WO2007149482A2
(en)
*
|
2006-06-20 |
2007-12-27 |
Metaproteomics, Llc |
Xanthohumol based protein kinase modulation cancer treatment
|
|
CN100431542C
(zh)
*
|
2006-11-07 |
2008-11-12 |
暨南大学 |
育亨宾和小檗碱混合在制药中的应用
|
|
US8815306B2
(en)
*
|
2007-03-19 |
2014-08-26 |
Metaproteomics, Llc |
Methods and compositions for promoting bone and joint health
|
|
AU2008251756B2
(en)
*
|
2007-05-11 |
2013-06-06 |
Metaproteomics, Llc |
Methods and compositions for heavy metal detoxification
|
|
CA2708613A1
(en)
*
|
2007-12-10 |
2009-06-18 |
Metaproteomics, Llc |
Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
|
|
CA2716080C
(en)
|
2008-02-20 |
2016-12-13 |
Targia Pharmaceuticals |
Cns pharmaceutical compositions and methods of use
|
|
NZ588927A
(en)
*
|
2008-04-02 |
2013-02-22 |
Metaproteomics Llc |
Substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
|
|
CN103181896B
(zh)
*
|
2011-12-30 |
2015-10-14 |
沈阳药科大学 |
一种含有小檗胺类药物的脂质体制剂及其制备方法
|
|
US10500169B2
(en)
*
|
2014-09-17 |
2019-12-10 |
Xiu-Min Li |
Supression of IgE production by compounds derived from traditional chinese medicine
|
|
KR101852148B1
(ko)
|
2015-06-26 |
2018-04-25 |
한국생명공학연구원 |
타입 III 에펙터 HopQ1 및 LIM 도메인 키나아제1(LIMK1)의 상호작용을 이용한 HopQ1에 의한 면역 억제에 대한 억제제 스크리닝 방법 및 이를 위한 조성물
|
|
CA3044746A1
(en)
*
|
2016-11-24 |
2018-05-31 |
Sigmadrugs Kutato Korlatolt Felelossegu Tarsasag |
Compositions for organ preservation
|
|
CN111053770B
(zh)
*
|
2019-12-23 |
2023-04-14 |
厦门大学 |
黄连素作为同种异体心脏移植中所使用的免疫抑制剂的应用
|
